Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$2.61 - $4.17 $912,978 - $1.46 Million
-349,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$2.91 - $4.32 $133,752 - $198,560
-45,963 Reduced 11.61%
349,800 $1.09 Million
Q4 2020

Feb 02, 2021

SELL
$2.15 - $3.5 $15,695 - $25,550
-7,300 Reduced 1.81%
395,763 $1.09 Million
Q3 2020

Nov 05, 2020

BUY
$2.77 - $6.17 $26,592 - $59,232
9,600 Added 2.44%
403,063 $1.15 Million
Q2 2020

Aug 12, 2020

BUY
$0.87 - $3.13 $342,312 - $1.23 Million
393,463 New
393,463 $1.22 Million

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.